CClinicalTrials.gg
Not yet recruitingNCT07669350Updated Jun 25, 2026

Effect of Aquatic Therapy Program on Balance in Children With Spastic Diplegic Cerebral Palsy

An interventional study of aquatic therapy and land exercise program in Cerebral Palsy (CP), sponsored by Delta University for Science and Technology. Not yet recruiting. Open to participants aged 5 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-06-25.

Sponsored by Delta University for Science and Technology · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
5 Years to 12 Years
Sex
All
01

Study summary

  1. Evaluate the effect of a structured aquatic therapy programme on static balance in children with spastic diplegic cerebral palsy.
  2. Assess the effect of the same programme on dynamic balance in this patient population.
  3. Compare balance outcomes between children receiving aquatic therapy and those receiving conventional land-based physiotherapy.
Read the detailed description

Cerebral palsy (CP) is the most common cause of permanent motor disability in childhood, with spastic diplegia being the most prevalent subtype, characterized by bilateral lower limb spasticity, impaired postural control, and significantly compromised balance - deficits that restrict functional mobility and participation in daily activities. These balance impairments arise from disrupted selective motor control, abnormal muscle tone, reduced proprioceptive integration, and impaired neuromuscular coordination, and represent a central therapeutic target in paediatric rehabilitation. Aquatic therapy exploits the physical properties of water - buoyancy, hydrostatic pressure, warmth, and viscosity - to reduce spasticity, facilitate movement, and promote motor learning in a safe environment, with meta-analytic evidence confirming significant improvements in gross motor function compared to land-based approaches. However, studies specifically targeting balance as a primary outcome in children with spastic diplegic CP remain limited, representing a clinically important gap that this study seeks to address.

02

Conditions studied

  • Cerebral Palsy (CP)

Browse trials for

Keywords

  • Aquatic therapy
  • Diaplegia
  • cerebral palsy
03

In context

Cerebral Palsy

1,853 studies on the registry are indexed under Cerebral Palsy; 435 are open to participants now.

This study's planned enrollment of 50 is above the median of 33 across 1,368 interventional studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Delta University for Science and Technology is the lead sponsor of 82 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Confirmed diagnosis of spastic diplegic cerebral palsy by a paediatric neurologist or developmental paediatrician
  2. Age between 5 and 12 years
  3. Classified at GMFCS levels I-III
  4. Bilateral lower limb spasticity with a Modified Ashworth Scale (MAS) score of ≥ 1

Exclusion criteria

Exclusion Criteria:

  1. Athetoid, ataxic, or mixed-type cerebral palsy
  2. GMFCS levels IV or V (non-ambulatory children)
  3. Uncontrolled seizure disorder or epilepsy not managed by medication
  4. Open wounds, skin infections, or active dermatological conditions contraindicating water immersion
  5. Fear of water (aquaphobia) or inability to tolerate the aquatic environment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Study group

    study group will receive aquatic exercise therapy

    Other: aquatic therapy

  • Active comparator
    control group

    land exercise program

    Other: land exercise program

Interventions

  • Otheraquatic therapy

    Aquatic therapy is a specialized rehabilitation approach that utilizes the physical properties of water, including buoyancy, hydrostatic pressure, and resistance, to facilitate movement and improve functional performance in children with diplegic cerebral palsy. The aquatic environment reduces weight-bearing demands, allowing safer practice of balance, gait, strength, and motor control activities while minimizing joint stress. Regular aquatic therapy may enhance muscle strength, postural stability, mobility, and overall participation in daily activities.

  • Otherland exercise program

    The control group participated in a conventional land-based exercise program consisting of stretching, strengthening, balance, and functional mobility exercises. The program focused on improving lower-extremity muscle strength, postural control, gait performance, and overall functional abilities through activities performed on a stable surface. Exercises were progressed according to each participant's abilities while maintaining consistency in treatment duration and frequency across the study groups.

06

What researchers measure

Primary outcomes

  1. static balance

    Static and dynamic balance will be assessed using the Biodex Balance System. Stability indices will be recorded to evaluate postural control and balance performance

    Time frame: baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — confidentiality of the research

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07669350
Lead sponsor
Delta University for Science and Technology
Responsible party
Ibrahim Ahmed Ibrahim Abu Ella (lecturer, Delta University for Science and Technology) — Principal investigator
First posted
Jun 25, 2026
Start date
Jun 25, 2026 (estimated)
Primary completion
Sep 1, 2026 (estimated)
Completion
Sep 15, 2026 (estimated)
Last update
Jun 25, 2026

Study contacts

ibrahim A abu ella, Phd
Contact
ibrahimneuron@gmail.com
+201008442281

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion